Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

REPL Replimune Group Inc.

盘前交易 12-23 05:10:01 EST

12.49

+0.48

+4.00%

最高13.04	最低11.43	成交量235.06万
今开11.78	昨收12.01	日振幅13.41%
总市值9.41亿	流通市值6.51亿	总股本7,534万
成交额2,954万	换手率4.51%	流通股本5,215万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"REPL","market":"US","secType":"STK","nameCN":"Replimune Group Inc.","latestPrice":12.49,"timestamp":1734728400000,"preClose":12.01,"halted":0,"volume":2350640,"delay":0,"floatShares":52145000,"shares":75340444,"eps":-3.199975,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.48,"latestTime":"12-23 05:10:01 EST","open":11.78,"high":13.04,"low":11.43,"amount":29536555.558,"amplitude":0.134055,"askPrice":17,"askSize":104,"bidPrice":10.53,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-3.199975,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"listingDate":1532059200000,"adjPreClose":12.49,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":12.49,"preClose":12.49,"latestTime":"18:00 EST","volume":55763,"amount":696515.39,"timestamp":1734735630590},"volumeRatio":2.6087545670226175,"impliedVol":0.1267,"impliedVolPercentile":0.008},"requestUrl":"/m/hq/s/REPL","defaultTab":"news","newsList":[{"id":"2493781548","title":"美国研究综述-赫希、Paychex、Revvity","url":"https://stock-news.laohu8.com/highlight/detail?id=2493781548","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493781548?lang=zh_cn&edition=full","pubTime":"2024-12-23 15:07","pubTimestamp":1734937640,"startTime":"0","endTime":"0","summary":"美国研究综述-赫希、Paychex、Revvity路透12月23日 - 华尔街证券分析师周一调整了对包括好时、Paychex 和 Revvity 在内的几家美国上市公司的评级和目标价。要闻 * 好时HSY.N：杰富瑞将目标价从155美元下调至150美元 * Paychex Inc PAYX.O：贝尔德将目标价从139美元上调至143美元 * Revvity Inc RVTY.N：杰富瑞将目标价从125美元下调至120美元 * Vertex Pharmaceuticals Inc VRTX.O：丰业银行将目标价从426美元上调至430美元 * Winnebago Industries Inc WGO.N：杰富瑞将目标价从58美元下调至55美元以下是路透周一报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nL4S3NO0D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","HSY","IIPR","LU0114720955.EUR","SJM","RVTY","WGO","LEGN","IE00BZ9MQY76.HKD","HALO","LW","FLO","NBIX","REPL","BK4588","VRTX","LU1035775433.USD","BK4079","LU0054578231.USD","AADI","01548","IE00B19Z9Z06.USD","SYK","VITL","BK1576","PIPR","LEN","LU0128526141.USD","LU2089984988.USD","PAYX","UNIT","LU0109394709.USD","HK0000320264.USD","BGS","BK1141","BK4139","BK4099","GB00B4QBRK32.GBP","LU0234570918.USD","IE00BJT1NW94.SGD","KNF","MGPI","LU0417517546.SGD","CVGW","JLL","IONS","LU1430594728.SGD","LU0320765992.SGD","IE00BJJMRZ35.SGD","LU0690374961.EUR"],"gpt_icon":0},{"id":"2492401914","title":"Replimune Group, Inc.盘中异动 早盘大幅拉升5.15%报12.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492401914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492401914?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:01","pubTimestamp":1734706909,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日23时01分，Replimune Group, Inc.股票出现异动，股价大幅上涨5.15%。截至发稿，该股报12.63美元/股，成交量14.2671万股，换手率0.19%，振幅8.91%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Humacyte, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为2094.67%、99.08%、56.77%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为84.80%、48.53%、44.81%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220230149984cfd0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220230149984cfd0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2492676399","title":"Replimune Group, Inc.盘中异动 快速跳水5.01%报11.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492676399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492676399?lang=zh_cn&edition=full","pubTime":"2024-12-18 00:17","pubTimestamp":1734452252,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日00时17分，Replimune Group, Inc.股票出现波动，股价急速跳水5.01%。截至发稿，该股报11.86美元/股，成交量10.6747万股，换手率0.14%，振幅3.77%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Portage Biotech Inc.、Polyrizon Ltd.涨幅较大，Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Polyrizon Ltd.较为活跃，换手率分别为1858.52%、300.71%、130.57%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Portage Biotech Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为137.26%、106.73%、95.10%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218001732984c9215&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218001732984c9215&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2486087887","title":"嗡嗡声--美国股票走势-高盛, Zoom, Rumble","url":"https://stock-news.laohu8.com/highlight/detail?id=2486087887","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486087887?lang=zh_cn&edition=full","pubTime":"2024-11-27 02:47","pubTimestamp":1732646870,"startTime":"0","endTime":"0","summary":"[.N美国东部时间13:30，道琼斯工业平均指数.DJI下跌0.05%，报44,713.15点；标准普尔500指数.SPX上涨0.38%，报6,010.24点；纳斯达克综合指数.IXIC上涨0.48%，报19,145.57点。标准普尔 500 指数.PG.INX百分比涨幅前三名是： ** NRG Energy Inc NRG.N，上涨 9.1. ** 星座能源公司CEG.OQ，上涨5.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nL3S3MX1L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DAL","UAL","EXAS","AMGN","COIN","SMTC","CRC","DVN","IE00BFTCPJ56.SGD","RUM","LU2023250504.SGD","REPL","WWD","APA","MARA","JBLU","SCCO","IE0002270589.USD","ASPI","LU0203201768.USD","LU1988902786.USD","MAXN","TOYO","ATRO","AMWD","DKS","LU0050427557.USD","GS","LU1066051498.USD","SJM","ALEC","MAC","RIOT","OVV","LU0278409577.USD","CVX","ALK","CPRI","SLNO","ARWR","LU2242646821.SGD","FCX","LU0689472784.USD","VKTX","LU0310800965.SGD","PINS","HUT"],"gpt_icon":1},{"id":"2486000091","title":"嗡嗡声--美国股票走势-Pinterest、百思买、雪佛龙","url":"https://stock-news.laohu8.com/highlight/detail?id=2486000091","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486000091?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:53","pubTimestamp":1732636408,"startTime":"0","endTime":"0","summary":"** Astronics Corp   : BUZZ - 因发行 1.5 亿美元可转换债券而下跌    ** Soleno Therapeutics Inc   : BUZZ - 因FDA延长对遗传性疾病药物的审查而下跌   ** Arrowhead Pharmaceuticals Inc   : BUZZ - 与 Sarepta 达成许可协议后跳涨    ** 帝国石油公司   ：** Suncor Energy Inc   ：** Canadian Natural Resources Ltd   : BUZZ - 加拿大石油公司在特朗普誓言征收新关税后下跌    ** Capri Holdings Ltd   :","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".SPX","ALEC","RUM","DKS","MAC","VKTX","ONB","SLNO","SQQQ","SMTC","ADI","F","ATRO","LLY","UDOW","AMWD",".IXIC","BBY","DXD","CRC","AMGN","DJX","EG",".DJI","HUT","WH","LDOS","GM","H","EXAS","ASPI","QID","CVX","MAXN","WWD","KSS","PSQ","QLD","REPL","ARWR","PINS","PSTX","CPRI","SJM"],"gpt_icon":1},{"id":"2486200199","title":"Replimune Group, Inc.盘中异动 早盘急速拉升5.58%报14.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486200199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486200199?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:45","pubTimestamp":1732632325,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时45分，Replimune Group, Inc.股票出现异动，股价大幅拉升5.58%。截至发稿，该股报14.00美元/股，成交量39.5341万股，换手率0.58%，振幅5.43%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Poseida Therapeutics, Inc.、Fate Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Oncternal Therapeutics, Inc.、Poseida Therapeutics, Inc.、木薯科学较为活跃，换手率分别为15.88%、12.82%、12.34%，振幅较大的相关个股有Citius Pharmaceuticals, Inc.、Fate Therapeutics, Inc.、Protagenic Therapeutics, Inc.，振幅分别为31.35%、24.59%、21.67%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126224525971a8a3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126224525971a8a3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2486069260","title":"嗡嗡声--美国股票走势-Rivian、富国银行、Woodward","url":"https://stock-news.laohu8.com/highlight/detail?id=2486069260","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486069260?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:20","pubTimestamp":1732630816,"startTime":"0","endTime":"0","summary":".N  ** Poseida Therapeutics Inc PSTX.O:BUZZ - 因罗氏公司15亿美元的收购而上涨三倍多 nL3N3MX0RD  ** Rivian Automotive Inc RIVN.O:BUZZ - 在获得 66 亿美元贷款以建设佐治亚州电动汽车工厂后上涨 nL3N3MX0QP  ** Kohl's Corp KSS.N:BUZZ - 在预测年度销售额将出现更大跌幅后下跌 nL3N3MX0X8. ** Hut 8 Mining Corp HUT.O：BUZZ - 加密股票因比特币疲软而下跌 nL3N3MX0WF  ** Zoom Video Communications Inc ZM.O:BUZZ - 股价下滑，原因是第三季度超预期增长后可能出现获利回吐。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nL3T3MX17D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADI","F","WH","CVX","LU0238689110.USD","ONB","AMGN","REPL","BK4551","MAXN","SG9999017495.SGD","WFC","EXAS","BK4525","EG","LU0648001328.SGD","SG9999014880.SGD","BK4599","LDOS","ALEC","LU1496350502.SGD","PSTX","H","SG9999018857.SGD","KSS","BK4566","RIVN","HUT","LU1623119135.USD","AMWD","GM","BBY","BK4570","LU0320765059.SGD","LU1162221912.USD","RUM","VKTX","CRC","SJM","LU1861558580.USD","SMTC","DKS","WWD","LU1280957306.USD","MAC"],"gpt_icon":1},{"id":"2486300550","title":"BUZZ-Replimune 大幅增资后走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2486300550","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486300550?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:00","pubTimestamp":1732629646,"startTime":"0","endTime":"0","summary":"BUZZ-Replimune 大幅增资后走低11月26日 - ** Replimune Group REPL.O股价盘前下跌0.8%，报13.15美元， 此前该生物技术公司获得的股本多于目标股本。** 截至本周一，继 2023 年股价下跌 69% 后，2024 年股价上涨 57(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nL3S3MX168:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1291159041.SGD","LU1032466523.USD","LU1571399168.USD","LU0225771236.USD","IE00B2B36J28.USD","BK4585","LU0868494617.USD","LU1670710661.SGD","LU0306806265.USD","LU1868836591.USD","LU1585245621.USD","LU0882574055.USD","LU2242652126.USD","LU1868837136.USD","BK4559","LU1074936037.SGD","BK4588","LU0225284248.USD","LU1868837300.USD","LU0096364046.USD","IE00BJT1NW94.SGD","LU0061475181.USD","LU0321505868.SGD","LU0237698245.USD","IE00BSNM7G36.USD","LU1868836757.USD","LU1323610961.USD","IE00BJJMRZ35.SGD","BMY","LU1430594728.SGD","BK4581","BK4139","IE00BFTCPJ56.SGD","LU2125154935.USD","LU1670711123.USD","LU1670710588.SGD","LU0114720955.EUR","LU1868836914.USD","LU1718418525.SGD","LU2133065610.SGD","LU1261432733.SGD","REPL","LU0306807586.USD","LU0985481810.HKD","LU1093756168.USD","LU1670711040.USD","IE0002141913.USD","BK4007","LU0321505439.SGD","BK4534"],"gpt_icon":0},{"id":"2486381330","title":"Replimune Group, Inc.盘中异动 急速跳水5.02%报14.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486381330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486381330?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:32","pubTimestamp":1732545157,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时32分，Replimune Group, Inc.股票出现波动，股价大幅下跌5.02%。截至发稿，该股报14.18美元/股，成交量9.1019万股，换手率0.13%，振幅5.43%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，Scholar Rock Holding Corporation、Citius Pharmaceuticals, Inc.、Bridgebio Pharma, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为86.34%、59.17%、37.29%，振幅较大的相关个股有Anixa Biosciences, Inc.、Kodiak Sciences Inc、Werewolf Therapeutics, Inc.，振幅分别为105.47%、105.01%、104.19%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223237971a859f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223237971a859f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2485926128","title":"Replimune Group, Inc.股价上涨22.99% 市值涨2.14亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485926128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485926128?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:31","pubTimestamp":1732285881,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时31分，Replimune Group, Inc.股票出现异动，股价急速拉升22.99%。截至发稿，该股报13.59美元/股，成交量6.1565万股，换手率0.09%，振幅1.45%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Replimune Group, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Molecular Templates, Inc.、Exicure, Inc.较为活跃，换手率分别为503.55%、62.42%、36.25%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Exicure, Inc.，振幅分别为13.37%、12.77%、10.96%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223121abd791af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223121abd791af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139","VRPX","BK4007"],"gpt_icon":0},{"id":"2484975915","title":"Replimune Group, Inc.2024财年第三财季实现净利润-53.06百万美元，同比增加11.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484975915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484975915?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010418,"startTime":"0","endTime":"0","summary":"11月19日，Replimune Group, Inc.公布财报，公告显示公司2024财年第三财季净利润为-53.06百万美元，同比增加11.63%；其中营业收入为0.00美元，每股基本收益为-0.68美元。从资产负债表来看，Replimune Group, Inc.总负债1.17亿美元，其中短期债务3.96百万美元，资产负债比为4.26，流动比率为0.11。机构评级：截至2024年11月19日，当前有9家机构对Replimune Group, Inc.目标价做出预测，其中目标均价为16.00美元，其中最低目标价为14.00美元，最高目标价为18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180027abcedeb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180027abcedeb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL"],"gpt_icon":0},{"id":"2482846390","title":"Replimune Group Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482846390","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482846390?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:27","pubTimestamp":1731425275,"startTime":"0","endTime":"0","summary":"Replimune Group Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要Replimune Group Inc REPL.OQ报告，截至9月30日的季度调整后每股亏损68美分，高于去年同期的每股-90美分。七位分析师对该季度的平均预期是每股亏损 77 美分。Replimune Group Inc公布的季度每股收益为亏损68美分。该公司当季亏损 5306 万美元。Replimune Group Inc 的股价本季度上涨了 14.1%，今年迄今为止上涨了 48.3%。华尔街对 Replimune Group Inc 的 12 个月目标价中位数为 16.00 美元。本摘要由 LSEG 11 月 12 日 03:26 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL4T3MJ1O4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2482086530","title":"Replimune Group, Inc.盘中异动 早盘股价大跌6.16%报11.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482086530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482086530?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:32","pubTimestamp":1731421926,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时32分，Replimune Group, Inc.股票出现波动，股价急速下跌6.16%。截至发稿，该股报11.73美元/股，成交量1.9342万股，换手率0.03%，振幅6.08%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223206a230be0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223206a230be0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2481490985","title":"Replimune Group, Inc.盘中异动 大幅上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481490985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481490985?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903513,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Replimune Group, Inc.股票出现波动，股价快速上涨5.16%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Macrogenics, Inc.涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1032.56%、98.35%、49.49%，振幅较大的相关个股有Vaxcyte, Inc.、Fate Therapeutics, Inc.、Nurix Therapeutics, Inc.，振幅分别为107.85%、107.84%、106.06%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223153971a4bca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223153971a4bca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2481607507","title":"Replimune Group Inc    预计每股亏损 77 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481607507","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481607507?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:11","pubTimestamp":1730902269,"startTime":"0","endTime":"0","summary":"   * Replimune Group Inc    预计在11月8日公布截至2024年9月30日的业绩时，季度收入将没有变化(预计)。*    * LSEG 的分析师平均预计 Replimune Group Inc 每股亏损 77 美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 8 个 \"强烈买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Replimune Group Inc 的 12 个月目标价中位数为 16.00 美元，高于其最新收盘价 12.02 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Replimune Group Inc    预计每股亏损 77 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REPL"],"gpt_icon":0},{"id":"2477605873","title":"Replimune Group, Inc.盘中异动 股价大涨5.02%报11.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477605873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477605873?lang=zh_cn&edition=full","pubTime":"2024-10-23 03:50","pubTimestamp":1729626604,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日03时50分，Replimune Group, Inc.股票出现异动，股价快速上涨5.02%。截至发稿，该股报11.92美元/股，成交量38.2137万股，换手率0.56%，振幅6.30%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为1.02%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为6939.66%、5260.39%、2220.93%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.，振幅分别为189.27%、101.99%、99.41%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102303500598e3dd48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102303500598e3dd48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2475917297","title":"Replimune Group, Inc.盘中异动 临近午盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475917297","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475917297?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:32","pubTimestamp":1729092775,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时32分，Replimune Group, Inc.股票出现异动，股价快速上涨5.03%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，180 Life Sciences Corp.、Korro Bio, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为6105.14%、1084.16%、590.44%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.，振幅分别为623.68%、279.52%、126.58%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101623325598e3cd0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101623325598e3cd0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2474776148","title":"Replimune Group, Inc.盘中异动 临近收盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474776148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474776148?lang=zh_cn&edition=full","pubTime":"2024-10-11 03:41","pubTimestamp":1728589294,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日03时41分，Replimune Group, Inc.股票出现异动，股价急速下跌5.01%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Aditxt, Inc.、Tempest Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为565.98%、200.48%、112.06%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Tc Biopharm  Plc C/Wts 10/02/2028 、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为106.67%、75.00%、66.67%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410110341359719f937&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410110341359719f937&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2474057554","title":"Replimune Group, Inc.盘中异动 急速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474057554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474057554?lang=zh_cn&edition=full","pubTime":"2024-10-09 00:54","pubTimestamp":1728406460,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日00时54分，Replimune Group, Inc.股票出现异动，股价大幅拉升5.12%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Portage Biotech Inc.、Bio-Path Holdings, Inc.涨幅较大，Aditxt, Inc.、Bio-Path Holdings, Inc.、Gri Bio, Inc.较为活跃，换手率分别为2492.91%、2384.07%、257.20%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Virios Therapeutics, Inc.、Bio-Path Holdings, Inc.，振幅分别为66.06%、46.27%、45.80%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009005421a1df14ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009005421a1df14ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2472642400","title":"Replimune Group, Inc.盘中异动 下午盘急速下挫5.05%报11.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472642400","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472642400?lang=zh_cn&edition=full","pubTime":"2024-10-04 02:22","pubTimestamp":1727979740,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日02时22分，Replimune Group, Inc.股票出现波动，股价大幅下挫5.05%。截至发稿，该股报11.65美元/股，成交量30.9191万股，换手率0.45%，振幅7.82%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为1.77%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410040222209719e3c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410040222209719e3c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","REPL","BK4183","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.replimune.com","stockEarnings":[{"period":"1week","weight":-0.0048},{"period":"1month","weight":0.1122},{"period":"3month","weight":0.1448},{"period":"6month","weight":0.4694},{"period":"1year","weight":0.6221},{"period":"ytd","weight":0.4816}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Replimune Group, Inc.于2015年在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，致力于应用他们在溶瘤免疫治疗领域的领先专业技术，改变癌症患者的生活。使用该公司专有的Immulytic平台来设计和开发旨在最大限度激活免疫系统对抗癌症的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.002034},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.066883},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.078936},{"month":4,"riseRate":0.5,"avgChangeRate":0.137961},{"month":5,"riseRate":0.5,"avgChangeRate":-0.043196},{"month":6,"riseRate":0.833333,"avgChangeRate":0.254496},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.06263},{"month":8,"riseRate":0.428571,"avgChangeRate":0.059963},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.031249},{"month":10,"riseRate":0.571429,"avgChangeRate":0.117506},{"month":11,"riseRate":0.571429,"avgChangeRate":0.0375},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.091605}],"exchange":"NASDAQ","name":"Replimune Group Inc.","nameEN":"Replimune Group Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Replimune Group Inc.(REPL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Replimune Group Inc.,REPL,Replimune Group Inc.股票,Replimune Group Inc.股票老虎,Replimune Group Inc.股票老虎国际,Replimune Group Inc.行情,Replimune Group Inc.股票行情,Replimune Group Inc.股价,Replimune Group Inc.股市,Replimune Group Inc.股票价格,Replimune Group Inc.股票交易,Replimune Group Inc.股票购买,Replimune Group Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Replimune Group Inc.(REPL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}